What is CiiTECH?
Founded in 2017, CiiTECH operates at the intersection of biotechnology and therapeutic cannabis development. The company distinguishes itself by bridging the gap between Israel's advanced cannabis research ecosystem and the burgeoning consumer markets in the United Kingdom and Europe. By maintaining collaborative partnerships with premier research institutions, CiiTECH effectively translates complex scientific discoveries into commercialized therapeutic products. Its business model is further bolstered by a direct-to-consumer eCommerce platform, which facilitates the distribution of high-quality, Israeli-developed cannabis solutions to an international audience, positioning the firm as a key player in the global cannabinoid market.
How much funding has CiiTECH raised?
CiiTECH has raised a total of $241K across 1 funding round:
Private Equity
$241K
Private Equity (2021): $241K with participation from FastForward Innovations
Key Investors in CiiTECH
FastForward Innovations
FastForward Innovations Limited focuses on funding innovations to create future solutions, targeting potential investors looking for unique opportunities in venture capital and innovation-driven projects.
What's next for CiiTECH?
With the infusion of this latest capital, CiiTECH is well-positioned to scale its operational footprint and accelerate its product development pipeline. The company is expected to leverage these resources to deepen its research collaborations and enhance its supply chain logistics across European territories. As the regulatory landscape for therapeutic cannabis continues to evolve, CiiTECH's focus on evidence-based product commercialization provides a robust foundation for long-term growth. Future strategic efforts will likely prioritize the expansion of its eCommerce infrastructure and the pursuit of new clinical validation studies to maintain its competitive edge in the biotech industry.
See full CiiTECH company page
